Javelin Pharmaceuticals, Inc., a leading developer of novel acute care pain products, commented on the tender offer extension by Hospira, Inc. Hospira, Inc. announced today that Discus Acquisition Corporation, a wholly owned subsidiary of Hospira , is extending the tender offer to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc. .
Javelin Pharmaceuticals, Inc. comments on tender offer extension by Hospira